Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis
暂无分享，去创建一个
S. Ajroud‐Driss | M. Sweetser | H. Schmidt | A. González-Duarte | M. Schilling | D. Adams | A. Kristen | J. Berk | T. Brannagan | L. Obici | P. Gorevic | T. Coelho | J. Gillmore | Jihong Chen | T. Yamashita | Jing Jing Wang | C. Labeyrie | J. Franklin | S. Ajroud-Driss | H. Schmidt